Discover our partner website and enjoy its many special offers “2018 Launch”
DietCasa
DietCasa: More than 1000 organic and ecological products for a daily healthy and natural life!

DFV
Marboxidin 80 mg for dogs 100 chewable tablets

Treatment of skin and soft tissue infections, urinary tract infections and respiratory tract infections in dogs

Some countries require a prescription to be issued for the sale of this drug.

Marboxidin 80 mg is a brownish, oval, divisible and centre scored chewable tablet indicated for the treatment of infections:

  • In Dogs:
    • Skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by strains of microorganisms susceptible to marbofloxacin;
    • Urinary tract infections (UTI) associated or not with prostatitis or epididymitis caused by strains of microorganisms susceptible to marbofloxacin;
    • Respiratory tract infections caused by strains of microorganisms susceptible to marbofloxacin.

Each Marboxidin 80 mg tablet contains:

Active substance:

  • Marbofloxacin 80 mg

Excipients:

  • Glycerol distearate
  • Artificial beef flavour
  • Cellulose, microcrystalline
  • Starch, pregelatinized
  • Sodium starch glycolate (Type A)
  • Talc
  • Magnesium stearate

Marboxidin 80 mg:

  • Must not be used in dogs aged less than 12 months, or less than 18 months for exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese, Bouvier and Mastiffs, with a longer growth period.
  • Is not recommended to use in cats aged less than 16 weeks.
  • Must not be used in animals with known hypersensitivity to marbofloxacin or other (fluoro)quinolones

Marboxidin 80 mg polosogy:

  • For oral administration.
  • The recommended dose rate is 2 mg/kg body weight/day (1 tablet for 40 kg BW per day) in single daily administration.
  • To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing. Half of tablets can be administered.
  • Dogs:
    • In skin and soft tissue infections, treatment duration is at least 5 days. In superficial and severe pyoderma, treatment duration is at least 10 and 20 days, respectively. Depending on the course of the disease, it may be extended up to 40 days in urinary tract infections, treatment duration is at least 10 days. Depending on the course of the disease, it may be extended up to 28 days.
    • In respiratory infections, treatment duration is at least 7 days and depending on the course of the disease, it may be extended up to 21 days.

Marboxidin 80 mg is a brownish, oval, divisible and centre scored chewable tablet indicated for the treatment of infections:

  • In Dogs:
    • Skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by strains of microorganisms susceptible to marbofloxacin;
    • Urinary tract infections (UTI) associated or not with prostatitis or epididymitis caused by strains of microorganisms susceptible to marbofloxacin;
    • Respiratory tract infections caused by strains of microorganisms susceptible to marbofloxacin.

Each Marboxidin 80 mg tablet contains:

Active substance:

  • Marbofloxacin 80 mg

Excipients:

  • Glycerol distearate
  • Artificial beef flavour
  • Cellulose, microcrystalline
  • Starch, pregelatinized
  • Sodium starch glycolate (Type A)
  • Talc
  • Magnesium stearate

Marboxidin 80 mg:

  • Must not be used in dogs aged less than 12 months, or less than 18 months for exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese, Bouvier and Mastiffs, with a longer growth period.
  • Is not recommended to use in cats aged less than 16 weeks.
  • Must not be used in animals with known hypersensitivity to marbofloxacin or other (fluoro)quinolones

Marboxidin 80 mg polosogy:

  • For oral administration.
  • The recommended dose rate is 2 mg/kg body weight/day (1 tablet for 40 kg BW per day) in single daily administration.
  • To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing. Half of tablets can be administered.
  • Dogs:
    • In skin and soft tissue infections, treatment duration is at least 5 days. In superficial and severe pyoderma, treatment duration is at least 10 and 20 days, respectively. Depending on the course of the disease, it may be extended up to 40 days in urinary tract infections, treatment duration is at least 10 days. Depending on the course of the disease, it may be extended up to 28 days.
    • In respiratory infections, treatment duration is at least 7 days and depending on the course of the disease, it may be extended up to 21 days.
161.80
Order within 20h 45m 32s (before 12AM)
And receive your order
on Friday 15 December
AIR FREIGHT

Customers who buy this product, usually buy: